Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Quantification of the irreversible fibroblast growth factor receptor inhibitor futibatinib by UPLC-MS/MS: Application to the metabolic stability assay in human liver microsomes for the estimation of its in vitro hepatic intrinsic clearance, Journal of Pharmaceutical and Biomedical Analysis, May 2022, Elsevier,
DOI: 10.1016/j.jpba.2022.114731.
You can read the full text:
Contributors
The following have contributed to this page
